Therapeutic Application of Corticosteroids in COVID-19 : A Focus on Optimum Dose and Duration of Therapy

Errataetall:

CommentOn: BMC Infect Dis. 2021 Apr 10;21(1):337. - PMID 33838657

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Journal of clinical pharmacology - Vol. 61, No. 9 (2021), p. 1145-1148

Language:

English

Contributors:

Khiali, Sajad
Entezari-Maleki, Taher

Links:

Volltext

Keywords:

*COVID-19
7S5I7G3JQL
Acute respiratory distress syndrome (ARDS)
Adrenal Cortex Hormones
COVID-19
Comment
Corticosteroid
Cytokine release syndrome
Dexamethasone
Duration of Therapy
Humans
Journal Article
Methylprednisolone
SARS-CoV-2

Notes:

Date Completed 16.08.2021

Date Revised 10.09.2021

published: Print-Electronic

CommentOn: BMC Infect Dis. 2021 Apr 10;21(1):337. - PMID 33838657

Citation Status MEDLINE

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.1002/jcph.1929

PMID:

34157144

PPN (Catalogue-ID):

NLM32818005X